Isolation of a novel flavanonol and an alkylresorcinol with highly potent anti-trypanosomal activity from Libyan propolis
Siheri, Weam and Ebiloma, Godwin U. and Igoli, John O. and Gray, Alexander I. and Biddau, Marco and Akrachalanont, Pilaslak and Samya Sh M D Alenezi, Samya and Alwashih, Mohammad A. and Edrada Ebel, RuAngelie and Müller, Sylke and Lawrence, Catherine E. and Fearnley, James and Watson, David G. and De Koning, Harry P. (2019) Isolation of a novel flavanonol and an alkylresorcinol with highly potent anti-trypanosomal activity from Libyan propolis. Molecules, 24 (6). 1041. ISSN 1420-3049 (https://doi.org/10.3390/molecules24061041)
Preview |
Text.
Filename: Siheri_etal_Molecules_2019_Isolation_of_a_novel_flavanonol_and_an_alkylresorcinol_with_highly_potent_anti_trypanosomal_activity.pdf
Final Published Version License: Download (405kB)| Preview |
Abstract
Twelve propolis samples from different parts of Libya were investigated for their phytochemical constituents. Ethanol extracts of the samples and some purified compounds were tested against Trypanosoma brucei, Plasmodium falciparum and against two helminth species, Trichinella spiralis and Caenorhabditis elegans, showing various degrees of activity. Fourteen compounds were isolated from the propolis samples, including a novel compound Taxifolin-3-acetyl-4’-methyl ether (4), a flavanonol derivative. The crude extracts showed moderate activity against T. spiralis and C. elegans, while the purified compounds had low activity against P. falciparum. Anti-trypanosomal activity (EC50 = 0.7 µg/mL) was exhibited by a fraction containing a cardol identified as bilobol (10) and this fraction had no effect on Human Foreskin Fibroblasts (HFF), even at 2.0 mg/mL, thus demonstrating excellent selectivity. A metabolomics study was used to explore the mechanism of action of the fraction and it revealed significant disturbances in trypanosomal phospholipid metabolism, especially the formation of choline phospholipids. We conclude that a potent and highly selective new trypanocide may be present in the fraction.
ORCID iDs
Siheri, Weam ORCID: https://orcid.org/0000-0001-6569-7281, Ebiloma, Godwin U., Igoli, John O., Gray, Alexander I., Biddau, Marco, Akrachalanont, Pilaslak ORCID: https://orcid.org/0000-0001-5034-0327, Samya Sh M D Alenezi, Samya, Alwashih, Mohammad A. ORCID: https://orcid.org/0000-0001-5313-7877, Edrada Ebel, RuAngelie, Müller, Sylke, Lawrence, Catherine E. ORCID: https://orcid.org/0000-0001-9928-8451, Fearnley, James, Watson, David G. ORCID: https://orcid.org/0000-0003-1094-7604 and De Koning, Harry P.;-
-
Item type: Article ID code: 67337 Dates: DateEvent15 March 2019Published13 March 2019AcceptedSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 18 Mar 2019 13:58 Last modified: 11 Nov 2024 12:15 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/67337